First Needle-Free Patch RSV Vaccine Being Created
The U.S. National Institutes of Health (NIH) has granted the Biotech company Vaxxas Pty. Ltd. of Australia a worldwide license to a respiratory syncytial virus (RSV) antigen known as DS2. The license will allow for the firm to create the first needle-free and room-temperature stable RSV vaccine using a novel and “cutting edge” high-density microarray […]
“Needle-Free” Vaccines Pushed by Gates Foundation, U.S. Government
The pharmaceutical industry is continuing to receive funding from the Bill & Melinda Gates Foundation and the U.S. government to develop vaccines that can be administered without using a syringe. Last month, the Gates Foundation awarded a $23.6 million grant to Micron Biomedical, Inc. of Atlanta, Georgia to manufacture needle-free vaccines. This was followed by […]
U.S. Colleges, Companies Reinstate COVID Mask and Vaccine Mandates
Even though the World Health Organization (WHO) and U.S. government declared an end to the COVID-19 public health emergency in May 2023, some colleges and companies in the United States have announced they will be reinstating mandates to force people to wear masks and get COVID shots as a condition of getting a college education […]
3D Printed Vaccine Skin Patches Being Developed
In an attempt to increase consumer demand for COVID-19 shots, researchers have designed a vaccine printer that can print COVID messenger RNA (mRNA) skin patches in bulk, producing as many as 100 patches in 48 hours. The microneedle patches, which contain mRNA molecules in lipid nanoparticles, could pave the way for unlimited distribution of the […]
U.S. Facing Severe Shortage of Infectious Disease Physicians
In light of the COVID-19 pandemic, there has been a focus on the shortage of doctors opting to specialize in infectious disease. According to forecasts by the U.S. Health Resources and Services Administration (HRSA), the United States will face a serious shortage of infectious disease doctors with estimates showing that that by 2035 there will […]
Paxlovid May Interact With Common Heart Drugs and Cause Blood Clots, Bleeding, Arrhythmia and Muscle Weakness
Findings from a new study published in the Journal of American College of Cardiology found that administration of the anti-viral drug Paxlovid can interact with several commonly prescribed cardiovascular drugs and be associated with an increased risk for blood clots and bleeding, which are termed clinically relevant drug-to-drug interactions (DDI).1 Manufactured by Pfizer, Paxlovid is […]
